Related references
Note: Only part of the references are listed.RBCK1-related disease: A rare multisystem disorder with polyglucosan storage, auto-inflammation, recurrent infections, skeletal, and cardiac myopathy-Four additional patients and a review of the current literature
Rahul Phadke et al.
JOURNAL OF INHERITED METABOLIC DISEASE (2020)
Pulmonary glycogen deficiency as a new potential cause of respiratory distress syndrome
Giorgia Testoni et al.
HUMAN MOLECULAR GENETICS (2020)
Cardiomyopathy with lethal arrhythmias associated with inactivation of KLHL24
Carola Hedberg-Oldfors et al.
HUMAN MOLECULAR GENETICS (2019)
Skeletal Muscle Glycogen Chain Length Correlates with Insolubility in Mouse Models of Polyglucosan-Associated Neurodegenerative Diseases
Mitchell A. Sullivan et al.
CELL REPORTS (2019)
Targeting Pathogenic Lafora Bodies in Lafora Disease Using an Antibody-Enzyme Fusion
M. Kathryn Brewer et al.
CELL METABOLISM (2019)
Nuclear Glycogenolysis Modulates Histone Acetylation in Human Non-Small Cell Lung Cancers
Ramon C. Sun et al.
CELL METABOLISM (2019)
Central Nervous System Delivery and Biodistribution Analysis of an Antibody-Enzyme Fusion for the Treatment of Lafora Disease
Grant L. Austin et al.
MOLECULAR PHARMACEUTICS (2019)
The 4th International Lafora Epilepsy Workshop: Shifting paradigms, paths to treatment, and hope for patients
M. Kathryn Brewer et al.
EPILEPSY & BEHAVIOR (2019)
Mutations outside the N-terminal part of RBCK1 may cause polyglucosan body myopathy with immunological dysfunction: expanding the genotype-phenotype spectrum
Martin Krenn et al.
JOURNAL OF NEUROLOGY (2018)
Severe asymmetric muscle weakness revealing glycogenin-1 polyglucosan body myopathy
Tanya Stojkovic et al.
MUSCLE & NERVE (2018)
Lafora disease offers a unique window into neuronal glycogen metabolism
Matthew S. Gentry et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2018)
Rescue of GSDIII Phenotype with Gene Transfer Requires Liver- and Muscle-Targeted GDE Expression
Patrice Vidal et al.
MOLECULAR THERAPY (2018)
Inhibition of Glycogen Synthase II with RNAi Prevents Liver Injury in Mouse Models of Glycogen Storage Diseases
Natalie Pursell et al.
MOLECULAR THERAPY (2018)
GYG1 causing progressive limb girdle myopathy with onset during teenage years (polyglucosan body myopathy 2)
Mahalekshmi Desikan et al.
NEUROMUSCULAR DISORDERS (2018)
Astrocytes and neurons produce distinct types of polyglucosan bodies in Lafora disease
Elisabet Auge et al.
GLIA (2018)
Lafora disease - from pathogenesis to treatment strategies
Felix Nitschke et al.
NATURE REVIEWS NEUROLOGY (2018)
Exploring the elusive composition of corpora amylacea of human brain
Elisabet Auge et al.
SCIENTIFIC REPORTS (2018)
Guaiacol as a drug candidate for treating adult polyglucosan body disease
Or Kakhlon et al.
JCI INSIGHT (2018)
Polyglucosan myopathy and functional characterization of a novel GYG1 mutation
C. Hedberg-Oldfors et al.
ACTA NEUROLOGICA SCANDINAVICA (2018)
Cardiomyopathy as presenting sign of glycogenin-1 deficiency-report of three cases and review of the literature
Carola Hedberg-Oldfors et al.
JOURNAL OF INHERITED METABOLIC DISEASE (2017)
Glycogen Synthesis in Glycogenin 1-Deficient Patients: A Role for Glycogenin 2 in Muscle
Thomas O. Krag et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2017)
Triacylglycerol mimetics regulate membrane interactions of glycogen branching enzyme: implications for therapy
Rafael Alvarez et al.
JOURNAL OF LIPID RESEARCH (2017)
Antibody-mediated enzyme replacement therapy targeting both lysosomal and cytoplasmic glycogen in Pompe disease
Haiqing Yi et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2017)
Muscle glycogen synthesis and breakdown are both impaired in glycogenin-1 deficiency
Mads Godtfeldt Stemmerik et al.
NEUROLOGY (2017)
Single-Dose Gene-Replacement Therapy for Spinal Muscular Atrophy
J. R. Mendell et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Hemophilia B Gene Therapy with a High-Specific-Activity Factor IX Variant
L. A. George et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Rescue of Pompe disease in mice by AAV-mediated liver delivery of secretable acid α-glucosidase
Francesco Puzzo et al.
SCIENCE TRANSLATIONAL MEDICINE (2017)
Clinical heterogeneity and phenotype/genotype findings in 5 families with &ITGYG1&IT deficiency
Rabah Ben Yaou et al.
NEUROLOGY-GENETICS (2017)
A highly prevalent equine glycogen storage disease is explained by constitutive activation of a mutant glycogen synthase
C. A. Maile et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2017)
A novel image-based high-throughput screening assay discovers therapeutic candidates for adult polyglucosan body disease
Leonardo J. Solmesky et al.
BIOCHEMICAL JOURNAL (2017)
Update on new muscle glycogenosis
Pascal Laforet et al.
CURRENT OPINION IN NEUROLOGY (2017)
Lack of Glycogenin Causes Glycogen Accumulation and Muscle Function Impairment
Giorgia Testoni et al.
CELL METABOLISM (2017)
Start codon mutation of GYG1 causing late-onset polyglucosan body myopathy with nemaline rods
Giorgio Tasca et al.
JOURNAL OF NEUROLOGY (2016)
A novel neuromuscular form of glycogen storage disease type IV with arthrogryposis, spinal stiffness and rare polyglucosan bodies in muscle
Edoardo Malfatti et al.
NEUROMUSCULAR DISORDERS (2016)
Late-onset polyglucosan body myopathy in five patients with a homozygous mutation in GYG1
H. Orhan Akman et al.
NEUROMUSCULAR DISORDERS (2016)
Human HOIP and LUBAC deficiency underlies autoinflammation, immunodeficiency, amylopectinosis, and lymphangiectasia
Bertrand Boisson et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2015)
Muscle pathology and whole-body MRI in a polyglucosan myopathy associated with a novel glycogenin-1 mutation
Sushan Luo et al.
NEUROMUSCULAR DISORDERS (2015)
Familial polyglucosan body myopathy with unusual phenotype
M. Fanin et al.
NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY (2015)
A New Muscle Glycogen Storage Disease Associated with Glycogenin-1 Deficiency
Edoardo Malfatti et al.
ANNALS OF NEUROLOGY (2014)
Personalized Drug Discovery: HCA Approach Optimized for Rare Diseases at Tel Aviv University
Leonardo J. Solmesky et al.
COMBINATORIAL CHEMISTRY & HIGH THROUGHPUT SCREENING (2014)
Glycogen accumulation underlies neurodegeneration and autophagy impairment in Lafora disease
Jordi Duran et al.
HUMAN MOLECULAR GENETICS (2014)
Long-Term Safety and Efficacy of Factor IX Gene Therapy in Hemophilia B
A. C. Nathwani et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Antisense Oligonucleotide-mediated Suppression of Muscle Glycogen Synthase 1 Synthesis as an Approach for Substrate Reduction Therapy of Pompe Disease
Nicholas P. Clayton et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2014)
Inhibiting Glycogen Synthesis Prevents Lafora Disease in a Mouse Model
Bartholomew A. Pederson et al.
ANNALS OF NEUROLOGY (2013)
Polyglucosan Body Myopathy Caused by Defective Ubiquitin Ligase RBCK1
Johanna Nilsson et al.
ANNALS OF NEUROLOGY (2013)
Acute but transient neurological deterioration revealing adult polyglucosan body disease
Segolene Billot et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2013)
Whole-genome DNA/RNA sequencing identifies truncating mutations in RBCK1 in a novel Mendelian disease with neuromuscular and cardiac involvement
Kai Wang et al.
GENOME MEDICINE (2013)
Adult polyglucosan body disease: Natural History and Key Magnetic Resonance Imaging Findings
Fanny Mochel et al.
ANNALS OF NEUROLOGY (2012)
Juvenile-onset permanent weakness in muscle phosphofructokinase deficiency
Edoardo Malfatti et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2012)
Immunodeficiency, autoinflammation and amylopectinosis in humans with inherited HOIL-1 and LUBAC deficiency
Bertrand Boisson et al.
NATURE IMMUNOLOGY (2012)
Allele Copy Number and Underlying Pathology Are Associated with Subclinical Severity in Equine Type 1 Polysaccharide Storage Myopathy (PSSM1)
Rosie J. Naylor et al.
PLOS ONE (2012)
Targeting Cancer with a Lupus Autoantibody
James E. Hansen et al.
SCIENCE TRANSLATIONAL MEDICINE (2012)
Therapeutic in vivo gene transfer for genetic disease using AAV: progress and challenges
Federico Mingozzi et al.
NATURE REVIEWS GENETICS (2011)
Branching enzyme deficiency/glycogenosis storage disease type IV presenting as a severe congenital hypotonia Muscle biopsy and autopsy findings, biochemical and molecular genetic studies
A. L. Taratuto et al.
NEUROMUSCULAR DISORDERS (2010)
Brief Report: Glycogenin-1 Deficiency and Inactivated Priming of Glycogen Synthesis.
Ali-Reza Moslemi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Linear polyubiquitination: a new regulator of NF-κB activation
Kazuhiro Iwai et al.
EMBO REPORTS (2009)
Involvement of linear polyubiquitylation of NEMO in NF-κB activation
Fuminori Tokunaga et al.
NATURE CELL BIOLOGY (2009)
Glycogen synthase (GYS1) mutation causes a novel skeletal muscle glycogenosis
Molly E. McCue et al.
GENOMICS (2008)
Glycogen synthase 1 (GYS1) mutation in diverse breeds with polysaccharide storage myopathy
M. E. McCue et al.
JOURNAL OF VETERINARY INTERNAL MEDICINE (2008)
Unclassified polysaccharidosis of the heart and skeletal muscle in siblings
Benedikt Schoser et al.
MOLECULAR GENETICS AND METABOLISM (2008)
Muscle MRI findings in siblings with juvenile-onset acid maltase deficiency (Pompe disease)
Nomazulu Dlamini et al.
NEUROMUSCULAR DISORDERS (2008)
A Prevalent Variant in PPP1R3A Impairs Glycogen Synthesis and Reduces Muscle Glycogen Content in Humans and Mice (vol 5, pg e27, 2008)
David B. Savage et al.
PLOS MEDICINE (2008)
A prevalent variant in PPP1R3A impairs glycogen synthesis and reduces muscle glycogen content in humans and mice
David B. Savage et al.
PLOS MEDICINE (2008)
Brief report:: Cardiomyopathy and exercise intolerance in muscle glycogen storage disease 0
Gittan Kollberg et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Fatal infantile cardiac glycogenosis with phosphorylase kinase deficiency and a mutation in the γ2-subunit of AMP-Activated protein kinase
Hasan O. Akman et al.
PEDIATRIC RESEARCH (2007)
Intranuclear protein transduction through a nucleoside salvage pathway
James E. Hansen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Laforin, a dual specificity phosphatase that dephosphorylates complex carbohydrates
Carolyn A. Worby et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
A new mutation in PRKAG2 gene causing hypertrophic cardiomyopathy with conduction system disease and muscular glycogenosis
P Laforêt et al.
NEUROMUSCULAR DISORDERS (2006)
Glycogen storage diseases presenting as hypertrophic cardiomyopathy
M Arad et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Clinical and genetic heterogeneity of branching enzyme deficiency (glycogenosis type IV)
C Bruno et al.
NEUROLOGY (2004)
Lafora's disease: Towards a clinical, pathologic, and molecular synthesis
BA Minassian
PEDIATRIC NEUROLOGY (2001)
Mutation spectrum and predicted function of laforin in Lafora's progressive myoclonus epilepsy
BA Minassian et al.
NEUROLOGY (2000)
Share Paper
